Select Publications
Journal articles
2016, 'Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease', Parkinsonism and Related Disorders, 24, pp. 89 - 94, http://dx.doi.org/10.1016/j.parkreldis.2015.12.018
,2016, 'Animal modeling an oligodendrogliopathy--multiple system atrophy', Acta neuropathologica communications, 4, pp. 12, http://dx.doi.org/10.1186/s40478-016-0279-6
,2016, 'Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansions', Annals of Neurology, 79, pp. 295 - 305, http://dx.doi.org/10.1002/ana.24565
,2016, 'Neuropathology of α-synuclein propagation and braak hypothesis', Movement Disorders, 31, pp. 152 - 160, http://dx.doi.org/10.1002/mds.26421
,2016, 'A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients', British Journal of Dermatology, 175, pp. 1073 - 1075, http://dx.doi.org/10.1111/bjd.14662
,2016, 'Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy', Acta Neuropathologica, 131, pp. 87 - 102, http://dx.doi.org/10.1007/s00401-015-1509-x
,2016, 'Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism', The Lancet Neurology, 15, pp. 332 - 342, http://dx.doi.org/10.1016/S1474-4422(15)00380-4
,2016, 'Distinctive pathological mechanisms involved in primary progressive aphasias', Neurobiology of Aging, 38, pp. 82 - 92, http://dx.doi.org/10.1016/j.neurobiolaging.2015.10.017
,2016, 'Expanding the phenotypic associations of globular glial tau subtypes', Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 4, pp. 6 - 13, http://dx.doi.org/10.1016/j.dadm.2016.03.006
,2016, 'Neuroprotective Effects of a Smoothened Receptor Agonist against Early Brain Injury after Experimental Subarachnoid Hemorrhage in Rats.', Front Cell Neurosci, 10, pp. 306, http://dx.doi.org/10.3389/fncel.2016.00306
,2015, 'Early-onset axonal pathology in a novel P301S-Tau transgenic mouse model of frontotemporal lobar degeneration', Neuropathology and Applied Neurobiology, 41, pp. 906 - 925, http://dx.doi.org/10.1111/nan.12233
,2015, 'Progression in behavioral variant frontotemporal dementia: A longitudinal study', JAMA Neurology, 72, pp. 1501 - 1509, http://dx.doi.org/10.1001/jamaneurol.2015.2061
,2015, 'Aβ-dependent reduction of NCAM2-mediated synaptic adhesion contributes to synapse loss in Alzheimer's disease', Nature Communications, 6, http://dx.doi.org/10.1038/ncomms9836
,2015, 'Protective properties of lysozyme on β-amyloid pathology: Implications for Alzheimer disease', Neurobiology of Disease, 83, pp. 122 - 133, http://dx.doi.org/10.1016/j.nbd.2015.08.024
,2015, 'Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS', Acta Neuropathologica, 130, pp. 661 - 678, http://dx.doi.org/10.1007/s00401-015-1486-0
,2015, 'Eating behavior in frontotemporal dementia', Neurology, 85, pp. 1310 - 1317, http://dx.doi.org/10.1212/WNL.0000000000002018
,2015, 'Early in vivo effects of the human mutant amyloid-β protein precursor (hAβPPSwInd) on the mouse olfactory bulb', Journal of Alzheimer's Disease, 49, pp. 443 - 457, http://dx.doi.org/10.3233/JAD-150368
,2015, 'Is CHCHD10 Pro34Ser pathogenic for frontotemporal dementia and amyotrophic lateral sclerosis?', Brain, 138, pp. e385, http://dx.doi.org/10.1093/brain/awv115
,2015, 'Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD)', Neurobiology of Disease, 82, pp. 445 - 454, http://dx.doi.org/10.1016/j.nbd.2015.07.011
,2015, 'Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease', Movement Disorders, 30, pp. 1639 - 1647, http://dx.doi.org/10.1002/mds.26141
,2015, 'MDS clinical diagnostic criteria for Parkinson's disease', Movement Disorders, 30, pp. 1591 - 1601, http://dx.doi.org/10.1002/mds.26424
,2015, 'MDS research criteria for prodromal Parkinson's disease', Movement Disorders, 30, pp. 1600 - 1611, http://dx.doi.org/10.1002/mds.26431
,2015, 'Selective loss of oxytocin and vasopressin in the hypothalamus in early Huntington disease: A case study', Neuropathology and Applied Neurobiology, 41, pp. 843 - 848, http://dx.doi.org/10.1111/nan.12236
,2015, 'TDP-43 proteinopathies: Pathological identification of brain regions differentiating clinical phenotypes', Brain, 138, pp. 3110 - 3122, http://dx.doi.org/10.1093/brain/awv220
,2015, 'The differentiation of progressive supranuclear palsy', Neurodegenerative disease management, 5, pp. 385 - 388, http://dx.doi.org/10.2217/nmt.15.37
,2015, 'Unusual α-synuclein and cerebellar pathologies in a case of hereditary myoclonus-dystonia without SGCE mutation', Neuropathology and Applied Neurobiology, 41, pp. 837 - 842, http://dx.doi.org/10.1111/nan.12216
,2015, 'Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism', Proceedings of the National Academy of Sciences of the United States of America, 112, pp. E5308 - E5317, http://dx.doi.org/10.1073/pnas.1514475112
,2015, 'Effect of PSEN1 mutations on MAPT methylation in early-onset Alzheimer’s disease', Current Alzheimer Research, 12, pp. 745 - 751, http://dx.doi.org/10.2174/1567205012666150710110756
,2015, 'Inflammation is genetically implicated in Parkinson's disease', Neuroscience, 302, pp. 89 - 102, http://dx.doi.org/10.1016/j.neuroscience.2014.10.028
,2015, 'Neuropathologic assessment of participants in two multi-center longitudinal observational studies: The Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN)', Neuropathology, 35, pp. 390 - 400, http://dx.doi.org/10.1111/neup.12205
,2015, 'Re-evaluating the glio-centric view of multiple system atrophy by highlighting the neuronal involvement', Brain, 138, pp. 2116 - 2119, http://dx.doi.org/10.1093/brain/awv151
,2015, 'Spread of pathology in amyotrophic lateral sclerosis: assessment of phosphorylated TDP-43 along axonal pathways', Acta neuropathologica communications, 3, pp. 47, http://dx.doi.org/10.1186/s40478-015-0226-y
,2015, 'Long intervening non-coding RNA 00320 is human brain-specific and highly expressed in the cortical white matter', Neurogenetics, 16, pp. 201 - 213, http://dx.doi.org/10.1007/s10048-015-0445-1
,2015, 'Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology', Neurobiology of Disease, 79, pp. 81 - 99, http://dx.doi.org/10.1016/j.nbd.2015.04.009
,2015, 'FTD and ALS-translating mouse studies into clinical trials', Nature Reviews Neurology, 11, pp. 360 - 366, http://dx.doi.org/10.1038/nrneurol.2015.65
,2015, 'Validation of the Psychosis and Hallucinations Questionnaire in Non-demented Patients with Parkinson's Disease', Movement Disorders Clinical Practice, 2, pp. 175 - 181, http://dx.doi.org/10.1002/mdc3.12139
,2015, 'PART is part of Alzheimer disease', Acta Neuropathologica, 129, pp. 749 - 756, http://dx.doi.org/10.1007/s00401-015-1390-7
,2015, 'Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias', Movement Disorders, 30, pp. 796 - 804, http://dx.doi.org/10.1002/mds.26144
,2015, 'Abnormal connectivity between the default mode and the visual system underlies the manifestation of visual hallucinations in Parkinson's disease: A task-based fMRI study', Parkinson's Disease, 1, http://dx.doi.org/10.1038/npjparkd.2015.3
,2015, 'Eating Behaviour and Metabolic Changes across the Spectrum of Motor Neuron Disease and Frontotemporal Dementia. (I12-5E)', Neurology, 84, http://dx.doi.org/10.1212/wnl.84.14_supplement.i12-5e
,2015, 'Eating Behaviour and Metabolic Changes across the Spectrum of Motor Neuron Disease and Frontotemporal Dementia. (P1.225)', Neurology, 84, http://dx.doi.org/10.1212/wnl.84.14_supplement.p1.225
,2015, 'Reply: Lysosomal dysfunction in Parkinson's disease', Brain, 138, pp. e340, http://dx.doi.org/10.1093/brain/awu268
,2015, 'Transcriptome analysis of grey and white matter cortical tissue in multiple system atrophy', Neurogenetics, 16, pp. 107 - 122, http://dx.doi.org/10.1007/s10048-014-0430-0
,2015, 'Aneuploidy in Lewy body diseases', Neurobiology of Aging, 36, pp. 1253 - 1260, http://dx.doi.org/10.1016/j.neurobiolaging.2014.12.016
,2015, 'Progressive supranuclear palsy finally has a clinically measureable τ abnormality', Journal of Neurology, Neurosurgery and Psychiatry, 86, pp. 241, http://dx.doi.org/10.1136/jnnp-2014-308567
,2015, 'High expression of long intervening non-coding RNA OLMALINC in the human cortical white matter is associated with regulation of oligodendrocyte maturation', Molecular brain, 8, pp. 2, http://dx.doi.org/10.1186/s13041-014-0091-9
,2015, 'ABCA5 Regulates amyloid-β peptide production and is associated with Alzheimer's disease neuropathology', Journal of Alzheimer's Disease, 43, pp. 857 - 869, http://dx.doi.org/10.3233/JAD-141320
,2015, 'Fatty acid composition of the anterior cingulate cortex indicates a high susceptibility to lipid peroxidation in Parkinson's disease', Journal of Parkinson's Disease, 5, pp. 175 - 185, http://dx.doi.org/10.3233/JPD-140479
,2015, 'Restricted disease propagation in multiple system atrophy with prolonged survival', Neuropathology and Applied Neurobiology, 41, pp. 681 - 685, http://dx.doi.org/10.1111/nan.12195
,2015, 'SNCA gene, but not MAPT, influences onset age of Parkinson's disease in Chinese and Australians', BioMed Research International, 2015, http://dx.doi.org/10.1155/2015/135674
,